Kura Oncology (KURA) Insider Trading & Ownership $10.08 +0.65 (+6.89%) Closing price 10/8/2025 04:00 PM EasternExtended Trading$10.16 +0.08 (+0.79%) As of 07:14 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock Kura Oncology (NASDAQ:KURA) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage6.40%Number OfInsiders Buying(Last 12 Months)1Amount OfInsider Buying(Last 12 Months)$410.00KNumber OfInsiders Selling(Last 12 Months)6Amount OfInsider Selling(Last 12 Months)$817.65K Get KURA Insider Trade Alerts Want to know when executives and insiders are buying or selling Kura Oncology stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. KURA Insider Buying and Selling by Quarter Kura Oncology Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame Start Date End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails9/29/2025Brian T PowlInsiderSell8,891$8.94$79,485.54 9/29/2025Kathleen FordCOOSell6,892$8.94$61,614.48 9/29/2025Mollie LeoniInsiderSell12,314$8.94$110,087.16 9/29/2025Teresa Brophy BairInsiderSell8,805$8.94$78,716.70 9/29/2025Thomas James DoyleSVPSell4,541$8.94$40,596.54 9/29/2025Troy Edward WilsonCEOSell36,615$8.94$327,338.10 9/8/2025Troy Edward WilsonCEOBuy50,000$8.20$410,000.00 5/19/2025Kathleen FordCOOSell1,558$6.28$9,784.24 5/19/2025Teresa Brophy BairInsiderSell1,559$5.96$9,291.64 1/28/2025Kathleen FordCOOSell1,817$7.87$14,299.79 1/28/2025Mollie LeoniInsiderSell4,963$7.87$39,058.81 1/28/2025Thomas James DoyleSVPSell4,949$7.87$38,948.63 11/18/2024Kathleen FordCOOSell526$16.03$8,431.78 (Data available from 1/1/2013 forward) KURA Insider Trading Activity - Frequently Asked Questions Who is on Kura Oncology's Insider Roster? The list of insiders at Kura Oncology includes Brian T Powl, Kathleen Ford, Kirsten Flowers, Mollie Leoni, Teresa Brophy Bair, Thomas James Doyle, Thomas Malley, and Troy Edward Wilson. Learn more on insiders at KURA. What percentage of Kura Oncology stock is owned by insiders? 6.40% of Kura Oncology stock is owned by insiders. Learn more on KURA's insider holdings. Which Kura Oncology insiders have been buying company stock? The following insider purchased KURA shares in the last 24 months: Troy Edward Wilson ($410,000.00). How much insider buying is happening at Kura Oncology? Insiders have purchased a total of 50,000 KURA shares in the last 24 months for a total of $410,000.00 bought. Which Kura Oncology insiders have been selling company stock? The following insiders have sold KURA shares in the last 24 months: Brian T Powl ($79,485.54), Kathleen Ford ($120,759.09), Mollie Leoni ($149,145.97), Teresa Brophy Bair ($182,473.99), Thomas James Doyle ($120,805.57), and Troy Edward Wilson ($2,169,320.06). How much insider selling is happening at Kura Oncology? Insiders have sold a total of 192,964 Kura Oncology shares in the last 24 months for a total of $2,821,990.22 sold. Kura Oncology Key ExecutivesDr. Troy Edward Wilson J.D. (Age 55)Ph.D., Chairman, CEO & President Compensation: $1.22M2 recent tradesMs. Kathleen Ford (Age 77)Chief Operating Officer Compensation: $824.95k2 recent tradesMs. Teresa Brophy Bair Esq. (Age 53)J.D., Chief Legal Officer & Corporate Secretary Compensation: $705.38k2 recent tradesDr. Stephen Dale M.D. (Age 52)Chief Medical Officer Compensation: $855.3kMr. Thomas Doyle (Age 53)Senior Vice President of Finance & Accounting Mr. Pete De SpainExecutive Vice President of Investor Relations & Corporate CommunicationsDr. Roger Bakale Ph.D.Senior Vice President of Manufacturing & Supply ChainMs. Maureen Clancy M.B.A.VP and Global Head of Program Leadership & Project ManagementDr. Mollie Leoni M.D.Executive Vice President of Clinical DevelopmentMr. Brian T. Powl M.B.A. (Age 50)M.S., Chief Commercial Officer 1 recent trades More Insider Trading Tools from MarketBeat Related Companies Centessa Pharmaceuticals Insider Transactions AMNEAL PHARMACEUTICALS Insider Transactions uniQure Insider Transactions Xenon Pharmaceuticals Insider Transactions Viking Therapeutics Insider Transactions CG Oncology Insider Transactions Gemini Therapeutics Insider Transactions Immunovant Insider Transactions Apellis Pharmaceuticals Insider Transactions Ultragenyx Pharmaceutical Insider Transactions Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles Marvell Insiders Buy Shares—Should Investors Follow Suit?This Insider Just Made a Massive Bet on Transocean's ComebackInsider Sales Jump at Broadcom and CoreWeave: Red Flag Ahead?Oklo Insiders Sell! Oh No! This Is Why Investors Shouldn’t WorryTop Insider Buys and Sells From September: Buy, Sell, or Hold? This page (NASDAQ:KURA) was last updated on 10/9/2025 by MarketBeat.com Staff From Our PartnersMagnificent 7 being replaced by the “Hidden 7”?BULLISH: It's time to buy this 'hidden' AI stock An award-winning stock-rating system has turned BULLISH on...Chaikin Analytics | SponsoredAn $8 trillion-dollar discovery 17,000 ft underwater A strange rock pulled from the ocean floor may hold the key to a $16 trillion resource boom. Inside it: materi...Porter & Company | SponsoredREVEALED: Something Big Happening Behind White House DoorsWhat I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredURGENT: The Market's 3 Red Flags Are FlashingHere’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash befor...StockEarnings | Sponsored2013 miner reveals his trading systemWhile everyone else is gambling on meme coins or chasing the next "100x moonshot," our members are systematica...Crypto Swap Profits | SponsoredThe Tiny Stock Set to Soar with Musk's AI AmbitionsThe Tiny Stock Set to Soar with Musk's AI Ambitions While Musk builds one of the most ambitious AI empires ...Behind the Markets | SponsoredIf You Keep Cash In A U.S. Bank Account… Read This NOWThe Treasury Department just issued a stunning warning: U.S. banks could lose up to $6.6 trillion of custom...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Kura Oncology, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Kura Oncology With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
